Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Susquehanna Maintains Positive on Endava, Lowers Price Target to $66

Author: Benzinga Newsdesk | March 12, 2024 09:34am
Susquehanna analyst James Friedman maintains Endava (NYSE:DAVA) with a Positive and lowers the price target from $83 to $66.

Posted In: DAVA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist